An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression
Answers
Answered by
0
DNA Ligase IV is responsible for sealing of double-strand breaks (DSBs) during nonhomologous end-joining (NHEJ). Inhibiting Ligase IV could result in amassing of DSBs, thereby serving as a strategy toward treatment of cancer.
Similar questions